Allocations
Agribusiness and food company Bunge Limited is to acquire Climate Change Capital Limited (CCCG), a UK-regulated sustainable asset manager and advisor.


The transaction was approved by the UK’s Financial Services Authority (FSA) on 20 February, 2012, and CCCG has obtained the required shareholder approvals to proceed. The transaction is expected to close in the coming weeks; financial terms will not be disclosed.


Daniel Rudolph, Managing Director, Bunge Financial Services Group, says: "Bunge’s Financial Services Group has been active in carbon markets since their inception, both as a buyer of carbon credits and an advisor to other market participants. The transaction
Blackstar has entered into a conditional agreement for the sale of 72,989,078 ordinary shares in Litha Healthcare Group Limited to Paladin Labs Inc. The Disposal, for a cash consideration of GBP16.6 million, represents 50% of Blackstar’s interest in Litha and equates to ZAR2.75 per Litha share.
On completion, the Disposal proceeds will represent a 4.58 times return on investment in South African Rand and 5.36 times return in Pounds Sterling, which equates to a 32% IRR and 36% IRR, respectively, over the five year holding period. The Disposal proceeds will be applied against the Investec Bank Limited debt facility that
High Road Capital Partners’ portfolio company Advanced Sleep Medicine Services, Inc has completed the acquisition of Pacific Sleep Medicine Services, a provider of sleep disorder diagnostic services with laboratory facilities throughout Southern California. The acquisition closed on 17 February, 2012.
Pacific Sleep will become part of Advanced Sleep’s existing network of California-based sleep disorder diagnostic facilities.Advanced Sleep was acquired by High Road in May 2010.
“The addition of Pacific Sleep’s facilities is part of our overall strategy to expand Advanced Sleep’s presence throughout California both organically and through acquisitions,” says Bill Connell (pictured), the High Road Partner who led
Ceptaris Therapeutics, Inc, a privately held specialty pharmaceutical company, has secured USD15 million in venture debt financing from Silicon Valley Bank and Oxford Finance.
The New Drug Application (NDA) for Ceptaris’ drug candidate, mechlorethamine gel, is currently undergoing review by the US Food and Drug Administration (FDA) for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL).
Ceptaris received USD7.5 million at closing and has access to the remaining USD7.5 million if the NDA is approved by the FDA. The funding will be used for ongoing operational expenses and preparation for commercialization of
A record number of private equity add-on deals were completed in 2011 and the upward turn in transactions of this type is continuing into 2012, according to date released by Preqin.
While the number of deals of other types plummeted, the number of add-on deals completed during the downturn remained relatively consistent and has since more than doubled.
In January 2012, add-ons accounted for 35% of all completed deals, an increase from 2008/2009 when around a quarter of deals were of this type. Add-ons are generally small and mid-sized deals, so it is perhaps unsurprising that there has been a
Advent International and GS Capital Partners VI Fund, LP and certain of its affiliates have signed a definitive merger agreement to acquire TransUnion from its current stockholders, including Madison Dearborn Partners and the Pritzker family business interests.
The transaction, which is expected to close late first quarter or early second quarter of 2012, values TransUnion at over USD3 billion. TransUnion President and Chief Executive Officer Bobby Mehta and the rest of the company’s leadership team will remain with TransUnion.
“Since we spun TransUnion out of the Marmon Group we have extended the global footprint into more than a dozen countries
Capital Dynamics has held the final closing of Capital Dynamics Champion Ventures VII, a US-based venture program targeting top-tier US venture managers or pre-eminent international venture firms with strong US ties.
The final closing of Capital Dynamics Champion Ventures VII ends a successful fundraising for CapitalDynamics’ US-based venture capital program with a total of USD 111 million in committed capital. The program has already made several venture fund commitments. Many of these funds have commenced investing andsome of the funds have already experienced IPOs of underlying portfolio companies.
Capital Dynamics Champion Ventures VII builds on Capital Dynamics’ established network of
July Systems, a cloud-based mobile application platform provider, has closed a USD15 million growth equity investment led by Updata Partners with participation from Intel Capital and WestBridge Capital.
The latest round of funding will provide capital to accelerate the product roadmap, boost sales momentum and increase market reach.
"Our investment in July Systems represents our belief in the platform, the management team, and the mobile market," says Carter Griffin of Updata Partners, a leading technology-focused growth equity firm. "July Systems has a seasoned and highly experienced team, a market-leading product, and a top-tier, global customer base. We look forward to
Middle market private equity firm Parthenon Capital Partners has held the final closing of Parthenon Investors IV (PCP IV) with USD700 million in commitments. PCP IV exceeded its initial fund target of USD600 million and hit its “hard cap” of USD700 million.
“We appreciate the support we received from our existing limited partners and are also excited about the relationships we’ve developed with an outstanding group of new investors,” says Brian Golson (pictured), Managing Partner and San Francisco Office Head.
“We’re pleased that investors recognised our differentiated strategy, significant focus on proactive research, and strong track record,” says David Ament,
CS Strategic Partners, the exclusive dedicated secondary private equity arm of Credit Suisse, has announced the final close of its most recent fund, CS Strategic Partners V, with total capital commitments of over USS2.9 billion. Consistent with regulation, this capital includes over USS87 million committed by Credit Suisse and the Strategic Partner investment team.
SPV LBO Centric, SPV Real Estate and SPV Venture Secondary Funds began investing in the second half of 2011 and have to date already collectively invested or committed to invest approximately USD500 million to over 170 underlying funds in over 30 transactions. Strategic Partner’s pipeline is
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm